← Back to Clinical Trials
Recruiting NCT06487546
Repletion of Ergothioneine in Patients With Kidney Failure
Trial Parameters
Condition Esrd
Sponsor Stanford University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-04-01
Completion 2027-04-01
Interventions
Ergothioneine
Brief Summary
Dialysis removes potentially harmful chemicals from the blood but can also remove potentially valuable chemicals. One potentially valuable chemical called ergothioneine, which comes from the diet, is low in the blood of people receiving dialysis. For this research study, the investigators hope to learn how well a daily ergothioneine supplement will replenish the levels in the blood of people with kidney failure.
Eligibility Criteria
Inclusion Criteria: * kidney failure receiving hemodialysis or peritoneal dialysis Exclusion Criteria: * blood transfusion within 90 days * taking supplements which contain ergothioneine